Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) announced changes to its executive leadership and board on Thursday. According to a statement based on a recent SEC filing, Andy Sassine, Chief ...

The core of the LEGO Fortnite Ninjago update focuses on a fresh adventure tied to the Ninjago universe. You will essentially be traveling to a brand-new Ninjago Island, which will have: Temples, ...

Ashely Claudino is an Evergreen Staff Writer from Portugal. She has a Translation degree from the University of Lisbon (2020, Faculty of Arts and Humanities). Nowadays, she mostly writes Fortnite and ...

The LEGO NINJAGO The Old Town 15th Anniversary set has been unveiled, featuring 4,851 pieces and numerous references celebrating 15 years of the franchise The set includes a record 23 minifigures, ...

GameSpot may get a commission from retail offers. Lego Fortnite Odyssey is getting a Ninjago-themed makeover on Thursday, and for the very first time Epic Games will offer Fortnite versions of Lego ...

Fortnite's Chapter 7 Season 1 is set to explode with the LEGO Fortnite Odyssey x Ninjago crossover, launching December 11, 2025. Get ready for iconic Ninjago characters as new skins, ninja-themed ...

Epic Games has announced the next era of LEGO Fortnite, via its huge Ninjago: Rise of the Ninja update which lands later this week. Arriving ahead of Ninjago's 15th anniversary next year and in time ...

Shares of Arcturus Therapeutics ARCT have plunged 59.4% in the past three months. The massive stock price drop was primarily due to the mixed nature of the interim results reported by ARCT in late ...

Artwork for Fortnite's new Chapter Seven era has seemingly teased a crossover with LEGO Ninjago, and confirmed a return for the game's dreaded Cube. While LEGO already has a deep integration with ...

Arcturus Therapeutics (NASDAQ:ARCT) traded lower on Friday after Citi downgraded the San Diego, California-based biotech, citing mid-stage data the company posted this week for ARCT-032, a messenger ...

In a mixed interim data drop, Arcturus Therapeutics has revealed a lack of efficacy for its investigational inhaled mRNA therapy in cystic fibrosis (CF). The findings, shared today before market open, ...

Shares of Arcturus Therapeutics Holdings fell sharply premarket amid fears about patient complications in the wake of a mid-stage trial of a biotech spray treatment for cystic fibrosis that had mixed ...